Skip to main content
Back to Discussions

When AI designs a drug, who gets the credit?

Healthcare
Global
Started August 22, 2026

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…

Source Articles

Add Statement Analysis 0/5
Looking for a particular claim? Search all statements
🗳️ Join the conversation
10 statements to vote on • Your perspective shapes the analysis
📊 Progress to consensus analysis Needs 7+ participants and 20+ votes. Each statement joins once it has 3+ votes.
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Analysis can run once all three requirements are met.

Your votes count

No account needed. Your votes are saved and included in the consensus analysis. Create an account to keep a record of your votes.

CLAIM Posted by admin • Aug 22, 2026
AI's role in drug design should be recognized as transformative, warranting its inclusion in authorship and credit.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
Attributing credit to AI undermines the role of human expertise in drug development.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
The pharmaceutical industry must establish clear guidelines for attributing credit to AI and human contributors in drug discovery.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
The potential of AI in drug discovery should be acknowledged in scientific publications to reflect its contributions accurately.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
Collaborative efforts between AI and human researchers should be emphasized to foster innovation in drug development.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
AI should be credited as a co-inventor in drug discovery when it significantly contributes to the design process.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
Transparency in the drug discovery process is essential to determine how credit is assigned between AI and human researchers.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
AI systems that design drugs should be considered tools, not inventors, maintaining human primacy in the innovation process.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
Public trust in AI-generated drug discoveries hinges on clear attribution of credit and accountability.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results
CLAIM Posted by admin • Aug 22, 2026
Only human scientists should receive credit for drug discoveries, regardless of AI's involvement in the process.
Vote options for this statement: agree, disagree, or unsure
💬 View Discussion
Be first to respond
Vote to see results

💡 How this works

  • • Add statements: Post claims or questions (10 to 500 characters).
  • • Vote: Agree, disagree or unsure on each statement.
  • • Respond: Add detailed arguments for or against, with evidence.
  • • Consensus: Once enough people take part, analysis shows opinion groups and where they agree.

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us